CCAM
BSX icon

Codex Capital Asset Management’s Boston Scientific BSX Stock Holding History

Codex Capital Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
16,500
-16,800
-50% -$1.34M 0.4% 30
2025
Q4 		$3.18M Buy
+33,300
New +$3.26M 1.15% 24

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Codex Capital Asset Management's BSX Position: Q1 2026 in Review

Codex Capital Asset Management reduced its Boston Scientific (BSX) stake by 50% in Q1 2026, selling an estimated $1.34M and leaving 16,500 shares worth $1.04M. The position accounts for 0.4% of the portfolio, ranked #30.

Codex Capital Asset Management first reported a position in BSX in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.18M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Codex Capital Asset Management held 16,500 shares of Boston Scientific worth $1.04M as of Q1 2026.
  • Codex Capital Asset Management sold 16,800 Boston Scientific shares in Q1 2026, an estimated $1.34M.
  • Boston Scientific made up 0.4% of Codex Capital Asset Management's portfolio in Q1 2026, its #30 holding.
  • Codex Capital Asset Management first reported a position in Boston Scientific in Q4 2025 and has held it in 2 quarters since.
  • Codex Capital Asset Management's Boston Scientific position peaked at $3.18M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Codex Capital Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.